The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Fresenius Medical Care AG & Co KGaA

NYSE: FMS
Last

(U.S.) $36.99

Today's change+0.11 +0.30%
Updated December 19 4:07 PM EST. Delayed by at least 15 minutes.
 

Fresenius Medical Care AG & Co KGaA

NYSE: FMS
Last

(U.S.) $36.99

Today's change+0.11 +0.30%
Updated December 19 4:07 PM EST. Delayed by at least 15 minutes.

Fresenius Medical Care AG & Co KGaA up (U.S.)$0.11

Fresenius Medical Care AG & Co KGaA closed up Friday by (U.S.)$0.11 or 0.30% to (U.S.)$36.99. Over the last five days, shares have gained 0.98% and are currently 1.31% off of the 52-week high. Shares have underperformed the S&P 500 by 9.04% during the last year.

Key company metrics

  • Open(U.S.) $36.89
  • Previous close(U.S.) $36.88
  • High(U.S.) $37.23
  • Low(U.S.) $36.87
  • Bid / Ask-- / --
  • YTD % change+3.96%
  • Volume196,621
  • Average volume (10-day)160,233
  • Average volume (1-month)132,168
  • Average volume (3-month)129,637
  • 52-week range(U.S.) $31.28 to (U.S.) $37.48
  • Beta0.53
  • Trailing P/E21.17×
  • P/E 1 year forward21.82×
  • Forward PEG2.37×
  • Indicated annual dividend(U.S.) $0.53
  • Dividend yield1.42%
  • Trailing EPS(U.S.) $1.75
Updated December 19 4:07 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+8.12%

Based on its net profit margin of 8.12%, Fresenius Medical Care AG & Co KGaA is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.85%Sector:Industry:
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue4,1133,8353,5643,867
Total other revenue--------
Total revenue4,1133,8353,5643,867
Gross profit1,2881,2111,0821,301
Total cost of revenue2,8252,6232,4812,566
Total operating expense3,5233,2793,1193,206
Selling / general / administrative670631620620
Research & development30313031
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)1000
Other operating expenses, total--------
Operating income590556445661
Interest income (expense), net non-operating-111-111-112-111
Gain (loss) on sale of assets--------
Other--------
Income before tax491458349563
Income after tax329281247392
Income tax, total162177101171
Net income271234205349
Total adjustments to net income----00
Net income before extra. items271234205349
Minority interest-58-47-42-43
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items271234205349
Inc. avail. to common incl. extra. items271234205349
Diluted net income271234205349
Dilution adjustment----0--
Diluted weighted average shares303302302304
Diluted EPS excluding extraordinary itemsvalue per share0.890.770.681.15
Dividends per sharevalue per share0.000.000.000.48
Diluted normalized EPSvalue per share0.900.770.681.15